Found "AI": 1,117 results
Sort by
Relevance

A review of magnitude and impact of dental health system in Thailand (in Thai language)

This is a review of the magnitude and impact of dental health problems in Thailand. It reviews the effectiveness and cost-effectiveness of prevention intervention of dental measures both in Thailand and other countries. These findings will be sumitted to the Senate Standing Subcommittee for following up on the productin and the usage of dental pers

Economic evaluation of medical rehabilitation services for inpatient with stroke in the context of Thailand (in Thai language)

This study aims to determine the cost-effectiveness and cost-utility of medical rehabilitation services for inpatients suffering from a stroke. It will compare the outcome of medical rehabilitation services in terms of functional status and quality of life before and after service providing. Moreover, it will compare cost-effectiveness and cost-uti

Economic evaluation of routine offer of HIV counseling and testing of out patients at community hospitals in Thailand (in Thai language)

This study aims to evaluate the cost-utility of the routine offers of HIV counseling and testing in community hospitals compared with the current practice. It analyses this by using the social perspective and the payer prospective. The model-based economic evaluation was use to analyze this. Data about the quality of life of HIV infected patients a

Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand (in Thai language)

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

Development of population-based screening package in Thailand

This project aims to propose an additional and unified screening package for the Thai population, building upon that offered already by the UC, which will be useful to allocate resources more efficiently and reduce the inequity gap among the three insurance scheme beneficiary groups.   1. To prioritize diseases  for screening  based on availab

Health-Related Quality of Life Measure (EQ-5D-5L): Measurement Property Testing and its Preference-Based Score in Thai Population

This research aimed to develop the population-based preference scores of the EQ-5D-5L (the 5L), Thai version in an effort to compare the measurement properties of the 5L with those of the EQ-5D-3L (the 3L), and to compare the results of an economic evaluation from a 2014 study that used the 5L compared with the 3L. To elicit population-based prefer

Preventing end-stage renal disease in Thai newly-diagnosed severe lupus nephritis patients: cost-effectiveness of alternative drug regimens (research for development of the health benefit package under the Universal Coverage scheme)

The purpose of this study is to compare the cost-utility of each treatment option available today in order to determine the most cost-effective treatment compared with standard treatment in the social perspective. Research methodology is an economic evaluation by using the markov model to compare the cost and utility of treatment options of new pat

health system research topic prioritization of Thailand 2012

An aim of this project is to prioritise Health Technology Assessment (HTA) topics.Topic prioritisation process consists of three key principles namely,1) the entire process and results must be transparent;2) the process as well as the prioritised list should be reflect benefits of the society; and3) the participation from multiple groups of stakeho

Development of Thai HTA process guidelines

Although HITAP strictly follows national HTA methodological guidelines, questions over the good governance of research arose from a lack of formal process guidelines. Therefore, HITAP embarked on the development of HTA process guidelines in 2011. International guidelines were reviewed in order to develop a conceptual framework, with the aim of conn

Cost-utility analysis of dasatinib and nilotinib for chronic myeloid leukemia patients who fail to respond to first-line treatment with imatinib in Thailand

Imatinib, the first tyrosine kinase inhibitor (TKI) has been used widely as a first-line treatment for newly diagnosed CML patients. Approximately 20-30% of CML patients are resistant or intolerant to the drug, and half of these cases are due to a gene mutation in the ABL domain. Recently, second generation TKIs have emerged, such as dasatinib and
10 / Page